Celsion Corporation to Participate in the Virtual 33ʳᵈ Annual Roth Conference
26. Februar 2021 08:45 ET
|
Celsion CORP
LAWRENCEVILLE, N.J., Feb. 26, 2021 (GLOBE NEWSWIRE) -- Celsion Corporation (NASDAQ: CLSN), a clinical-stage development company focused on DNA-based immunotherapy and next-generation vaccines, today...